Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is developing Lucid-MS around the idea that multiple sclerosis disability can progress independently of relapses, known as progression independent of relapse activity (“PIRA”). A recent article discusses chronic active, or “smoldering,” lesions and compartmentalized inflammation within the central […]

Perpetuals.com (NASDAQ: PDC) announced that UpsideOnly, its risk-free trading and market prediction platform, has surpassed 300,000 users three months after its May 19, 2026, launch, representing average growth of more than 100,000 new users per month. UpsideOnly allows users to make market predictions using virtual money, while Perpetuals uses its own capital to trade on signals identified by its proprietary BayesShield AI. Eligible users who contribute to profitable signals […]

Wrap Technologies (NASDAQ: WRAP) , a global public safety technology company delivering intelligent detection, orchestration and response solutions designed for the next generation of autonomous public safety, announced the closing of its previously announced registered direct offering with a fundamental institutional investor and an existing investor consisting of 8,571,609 shares of common stock, or pre-funded warrants in lieu […]

Multiple sclerosis (“MS”) treatment has traditionally focused on controlling the immune activity that drives new inflammatory lesions and relapses. While this approach has transformed the management of relapsing MS, growing attention is being directed toward another fundamental challenge: protecting the nervous system from the damage that can accumulate over time and contribute to disability progression.  […]

MindWave Innovations (NYSE American: APUS) is positioning its proprietary MindChain as institutional-grade blockchain infrastructure designed to support the next phase of digital asset adoption. The insured Layer 2 network is intended to address institutional priorities such as security, compliance, scalability and efficient settlement while supporting applications including Bitcoin treasury management, decentralized finance and real-world asset tokenization. […]

Regentis Biomaterials (NYSE American: RGNT) is strengthening the manufacturing and intellectual property foundation behind its GelrinC cartilage-repair technology as it moves toward broader commercialization. The company recently received a Japanese Notice of Allowance for patent protection covering the organic solvent-free manufacturing process and ready-to-use liquid formulation behind GelrinC. This followed a recent U.S. issuance that expanded its […]

Greenland Mines (NASDAQ: GRML) was featured in an American News Group commentary examining the need for Western-aligned critical minerals supply chains spanning mining, processing, logistics and downstream markets. The article highlights Greenland Mines’ development-stage North Atlantic Critical Metals Corridor strategy, which seeks to connect Greenland resource assets with processing, logistics, offtake and end markets in […]

VERAXA Biotech (NASDAQ: VRXA) was featured in a recent article highlighting how its collaboration with AI-focused research organization Ardigen could strengthen the company’s oncology pipeline as artificial intelligence plays an increasingly important role in drug discovery. By combining Ardigen’s expertise in AI, computational biology and bioinformatics with VERAXA’s proprietary BiTAC(R) platform, the companies aim to use […]

Nanox (NASDAQ: NNOX), a leader in innovative medical imaging technology, announced that subsidiary Nanox AI Ltd. entered into a sales reseller agreement with Vertec Scientific Ltd. for the commercialization of its Nanox.AI bone solution, HealthOST, in the United Kingdom. The agreement grants Vertec an exclusive license to market and resell HealthOST in the UK, subject to minimum annual license commitments, for an initial three-year term. HealthOST is an FDA-cleared and UKCA/CE-marked AI […]

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing antiviral drugs, announced that a Phase II clinical trial of NV-387 Oral Gummies for treatment of the current Bundibugyo Ebolavirus and other Ebola viruses is expected to begin soon in the Democratic Republic of Congo (“DRC”). The company has received regulatory approval from local agency ACOREP […]

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, delivered another quarter of rapid top-line growth as demand for its SSi Mantra surgical robotic system continued to expand. The company reported second-quarter 2026 revenue of $13.9 million, an increase of 39.4% from $10.0 million a year earlier. Gross profit increased 20.0% to […]

USA Rare Earth (NASDAQ: USAR) reported second-quarter 2026 revenue of $5.8 million and approximately $1.53 billion in cash as of June 30. During the quarter, the company finalized agreements providing access to up to $1.6 billion in U.S. Department of Commerce CHIPS Act funding, announced a definitive agreement to acquire Serra Verde Group for approximately $2.8 billion and selected Blacksburg, South Carolina, for […]